Making Motion: On Assignment Inc. (NYSE:ASGN), Moelis & Company (NYSE:MC), F5 Networks (NASDAQ:FFIV), Aegerion Pharmaceuticals (NASDAQ:AEGR), Wells Fargo & Company (NYSE:WFC)


On Assignment Inc. (NYSE:ASGN) shares decreased -6.99% in last trading session and ended the day at $34.22. ASGN Gross Margin is 32.90% and its has a return on assets of 5.90%. On Assignment Inc. (NYSE:ASGN) quarterly performance is -6.83%.

On Assignment (NYSE: ASGN) reported Q1 EPS of $0.66, $0.06 better than the analyst estimate of $0.60. Revenue for the quarter came in at $582 million versus the consensus estimate of $552.76 million. GUIDANCE: On Assignment sees Q2 2016 EPS of $0.76-$0.79, versus the consensus of $0.77. On Assignment sees Q2 2016 revenue of $592-302 million, versus the consensus of $588.6 million.

Moelis & Company (NYSE:MC) ended the last trading day at $28.58. Company weekly volatility is calculated as 2.22% and price to cash ratio as 6.24. Moelis & Company (NYSE:MC) showed a weekly performance of 0.39%.

Moelis & Company (“we” or the “Firm”) (NYSE: MC) today reported financial results for the first quarter ended March 31, 2016. The Firm’s total revenues of $126.4 million for the quarter represented our largest first quarter of revenues on record and an increase of 27% from the prior year period. Adjusted Pro Forma net income was $19.6 million or $0.35 per share (diluted), as compared with $15.4 million or $0.28 per share (diluted) in the first quarter of 2015.

On 27 April, F5 Networks, Inc. (NASDAQ:FFIV) shares moved up 1.45% and was closed at $106.90. FFIV EPS growth in last 5 year was 22.00%. F5 Networks, Inc. (NASDAQ:FFIV) year to date (YTD) performance is 10.25%.

F5 Networks (NASDAQ: FFIV) reported Q2 EPS of $1.68, $0.05 better than the analyst estimate of $1.63. Revenue for the quarter came in at $490 million versus the consensus estimate of $485.93 million. GUIDANCE: F5 Networks sees Q3 2016 EPS of $1.77-$1.80, versus the consensus of $1.74. F5 Networks sees Q3 2016 revenue of $490-500 million, versus the consensus of $503 million. The company also announced today that its board of directors had authorized an additional $1 billion for the company’s common stock share repurchase program. This new authorization is incremental to the $73.8 million currently unused in the existing program which was initially authorized in October 2010.

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares decreased -4.22% in last trading session and ended the day at $2.95. AEGR Gross Margin is 78.20% and its has a return on assets of -16.50%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) quarterly performance is -56.49%.

On 11 April, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), announced that on March 14, 2016, Aegerion granted options to purchase 75,000 shares of common stock to one new employee; and on April 1, 2016, Aegerion granted options to purchase an aggregate of 57,775 shares of common stock to eight new employees under the inducement stock option program.

Wells Fargo & Company (NYSE:WFC) caters to the Financial space. It has a net profit margin of 41.90% and weekly performance is 0.95%. On the last day of trading company shares ended up at $50.93. Wells Fargo & Company (NYSE:WFC) distance from 50-day simple moving average (SMA50) is 4.10%.

Wells Fargo & Company (NYSE: WFC) announced a quarterly common stock dividend of $0.38 per share, an increase of a half-penny or 1 percent, per share from the prior quarter. The dividend is payable June 1, 2016, to stockholders of record on May 6, 2016, as approved today by the Wells Fargo board of directors. Wells Fargo has approximately 5.1 billion shares outstanding.


Leave a Reply

Your email address will not be published. Required fields are marked *